EN
EN
FR
ES
PT
AR
RU
DE
IT
NL
TH
KO
VI
ID
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium Butyricum and Bifidobacterium Capsule, Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Aflibercept Intravitreous Injection
Denosumab
Enzalutamide Soft Capsules
Sitagliptin Phosphate Tablets
Liraglutide Injection
Sevelamer Carbonate Tablets
Olaparib Tablets
Sorafenib Tablets
Eribulin Mesylate Injection
Neratinib Maleate Tablets
Lenalidomide Capsules
Trastuzumab Injection
Palbociclib Capsules
Semaglutide Injection
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and Innovation
Information
Video Center
Contact
Contact Us
Join Us
NEWS AND INFORMATION
Home
/
Kexing Biopharm...
Kexing Biopharm EU and US GMP Product List-20251023
Article source：
Oct 22,2025
View： 608
LABEL:
< Kexing Biopharm Product List-20251023
Kexing Biopharm EU and US GMP Product Introduction-20251023 >
BACK TO LIST
Related News
Aug 07,2025
Kexing Biopharm: Advancing Through Innovation and Internationalization
READ MORE >>
Feb 13,2024
Revolutionizing Medicine: The Rise of Recombinant Protein Drug Enterprises
READ MORE >>
Aug 28,2025
Adoption of Bevacizumab Biosimilars in Oncology Treatment: Trends, Challenges, and Future Prospects
READ MORE >>
Oct 22,2025
Kexing Biopharm EU and US GMP Product Introduction-20251023
READ MORE >>
May 08,2025
Why Is Kexing Biopharm the Leading Chinese Biological Products Factory?
READ MORE >>
Sep 06,2023
How to choose a suitable bevacizumab biosimilar manufacturer?
READ MORE >>
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium Butyricum and Bifidobacterium Capsule, Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Aflibercept Intravitreous Injection
Denosumab
Enzalutamide Soft Capsules
Sitagliptin Phosphate Tablets
Liraglutide Injection
Sevelamer Carbonate Tablets
Olaparib Tablets
Sorafenib Tablets
Eribulin Mesylate Injection
Neratinib Maleate Tablets
Lenalidomide Capsules
Trastuzumab Injection
Palbociclib Capsules
Semaglutide Injection
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and Innovation
Information
Video Center
Contact
Contact Us
Join Us
Article source：
Oct 22,2025
View：
608 
BACK TO LIST
Aug 07,2025
